Brief: Richter Says Pharma Revenues Grew By 11% YoY To HUF 237.5 Billion In Q2 2025
Aug 6 (Reuters) - Richter Gedeon Vegyeszeti Gyar Nyrt GDRB.BU: RICHTER: PHARMA REVENUES GREW BY 11% TO HUF 458BN IN H1 2025 RICHTER - FULL-YEAR GUIDANCE OF AROUND 10% INCREASE (EX-FX) IN BOTH REVENUES AND CLEAN EBIT IS MAINTAINED RICHTER - PHARMA REVENUES GREW BY 11% YOY TO HUF 237.5BN IN Q2 2025 RICHTER - H1 2025 REVENUES TO HUF 458BN RICHTER - NET PROFIT (ATTRIBUTABLE TO THE OWNERS OF THE PARENT) WAS HUF 120BN IN H1 2025 RICHTER - H1 2025 EBIT HUF 140.4BN Source text: https://tinyurl.com/5n6cnb58 Further company coverage: GDRB.BU ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Richter Gedeon Vegyeszeti Gyar Nyrt
See all newsAI in Hungary could unlock productivity gains of €15 billion, McKinsey says
Brief: Hungary's Richter and Hetero announce cooperation for development of semaglutide injection
Brief: Hungary's Richter and Acrux agree to license transdermal Estradiol spray for Australia
Brief: Hungary's Richter Says 2026 Guidance Fully Reiterated High-Single-Digit Growth In Revenues And Clean EBIT (At Constant Exchange Rates)
Brief: Hungary's Richter says European Commission granted approval for Tuyory, its biosimilar to Tocilizumab